Skip to content
← Full study record

NCT03206177 · MORE INFO

Limitations, agreements, and source contact

Paclitaxel/Carboplatin + Galunisertib for Patients With Carcinosarcoma of the Uterus or Ovary · Source last updated 2024-08-07

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
Kathleen-Moore@ouhsc.edu
organization
University of Oklahoma Health Sciences Center, Stephenson Cancer Center
phone
405-271-8777
title
Dr. Kathleen Moore
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
Kathleen-Moore@ouhsc.edu
organization
University of Oklahoma Health Sciences Center, Stephenson Cancer Center
phone
405-271-8777
title
Dr. Kathleen Moore

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice